Fig. 4

Sample predictions from the validation set for Safinamide mesylate (SAF), SAF impurity (4-HBD), SAF hydrolytic and oxidative degradation products developed by (a) PLS and (b) PCR models.

Sample predictions from the validation set for Safinamide mesylate (SAF), SAF impurity (4-HBD), SAF hydrolytic and oxidative degradation products developed by (a) PLS and (b) PCR models.